Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cells

Christine E. Nelson, Lauren J. Mills, Jennifer L. McCurtain, Emily A. Thompson, Davis M. Seelig, Siddheshvar Bhela, Clare F. Quarnstrom, Brian T. Fife, Vaiva Vezys

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Established T cell dysfunction is a barrier to antitumor responses, and checkpoint blockade presumably reverses this. Many patients fail to respond to treatment and/or develop autoimmune adverse events. The underlying reason for T cell responsiveness remains elusive. Here, we show that susceptibility to checkpoint blockade is dependent on the activation status of T cells. Newly activated self-specific CD8 T cells respond to checkpoint blockade and cause autoimmunity, which is mitigated by inhibiting the mechanistic target of rapamycin. However, once tolerance is established, self-specific CD8 T cells display a gene signature comparable to tumor-specific CD8 T cells in a fixed state of dysfunction. Tolerant self-specific CD8 T cells do not respond to single or combinatorial dosing of anti-CTLA4, anti–PD-L1, anti–PD-1, anti–LAG-3, and/or anti–TIM-3. Despite this, T cell responsiveness can be induced by vaccination with cognate antigen, which alters the previously fixed transcriptional signature and increases antigen-sensing machinery. Antigenic reeducation of tolerant T cells synergizes with checkpoint blockade to generate functional CD8 T cells, which eliminate tumors without concomitant autoimmunity and are transcriptionally distinct from classic effector T cells. These data demonstrate that responses to checkpoint blockade are dependent on the activation state of a T cell and show that checkpoint blockade-insensitive CD8 T cells can be induced to respond to checkpoint blockade with robust antigenic stimulation to participate in tumor control.

Original languageEnglish (US)
Pages (from-to)2640-2645
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume116
Issue number7
DOIs
StatePublished - Feb 12 2019

Fingerprint

T-Lymphocytes
Autoimmunity
Antigens
Neoplasms
Sirolimus
Vaccination
Genes

Keywords

  • CD8 T cells
  • Checkpoint
  • Dysfunction
  • Tolerance
  • Tumor

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Cite this

Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cells. / Nelson, Christine E.; Mills, Lauren J.; McCurtain, Jennifer L.; Thompson, Emily A.; Seelig, Davis M.; Bhela, Siddheshvar; Quarnstrom, Clare F.; Fife, Brian T.; Vezys, Vaiva.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, No. 7, 12.02.2019, p. 2640-2645.

Research output: Contribution to journalArticle

@article{d2e699b131724993a369a16ee29fc47e,
title = "Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cells",
abstract = "Established T cell dysfunction is a barrier to antitumor responses, and checkpoint blockade presumably reverses this. Many patients fail to respond to treatment and/or develop autoimmune adverse events. The underlying reason for T cell responsiveness remains elusive. Here, we show that susceptibility to checkpoint blockade is dependent on the activation status of T cells. Newly activated self-specific CD8 T cells respond to checkpoint blockade and cause autoimmunity, which is mitigated by inhibiting the mechanistic target of rapamycin. However, once tolerance is established, self-specific CD8 T cells display a gene signature comparable to tumor-specific CD8 T cells in a fixed state of dysfunction. Tolerant self-specific CD8 T cells do not respond to single or combinatorial dosing of anti-CTLA4, anti–PD-L1, anti–PD-1, anti–LAG-3, and/or anti–TIM-3. Despite this, T cell responsiveness can be induced by vaccination with cognate antigen, which alters the previously fixed transcriptional signature and increases antigen-sensing machinery. Antigenic reeducation of tolerant T cells synergizes with checkpoint blockade to generate functional CD8 T cells, which eliminate tumors without concomitant autoimmunity and are transcriptionally distinct from classic effector T cells. These data demonstrate that responses to checkpoint blockade are dependent on the activation state of a T cell and show that checkpoint blockade-insensitive CD8 T cells can be induced to respond to checkpoint blockade with robust antigenic stimulation to participate in tumor control.",
keywords = "CD8 T cells, Checkpoint, Dysfunction, Tolerance, Tumor",
author = "Nelson, {Christine E.} and Mills, {Lauren J.} and McCurtain, {Jennifer L.} and Thompson, {Emily A.} and Seelig, {Davis M.} and Siddheshvar Bhela and Quarnstrom, {Clare F.} and Fife, {Brian T.} and Vaiva Vezys",
year = "2019",
month = "2",
day = "12",
doi = "10.1073/pnas.1810326116",
language = "English (US)",
volume = "116",
pages = "2640--2645",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "7",

}

TY - JOUR

T1 - Reprogramming responsiveness to checkpoint blockade in dysfunctional CD8 T cells

AU - Nelson, Christine E.

AU - Mills, Lauren J.

AU - McCurtain, Jennifer L.

AU - Thompson, Emily A.

AU - Seelig, Davis M.

AU - Bhela, Siddheshvar

AU - Quarnstrom, Clare F.

AU - Fife, Brian T.

AU - Vezys, Vaiva

PY - 2019/2/12

Y1 - 2019/2/12

N2 - Established T cell dysfunction is a barrier to antitumor responses, and checkpoint blockade presumably reverses this. Many patients fail to respond to treatment and/or develop autoimmune adverse events. The underlying reason for T cell responsiveness remains elusive. Here, we show that susceptibility to checkpoint blockade is dependent on the activation status of T cells. Newly activated self-specific CD8 T cells respond to checkpoint blockade and cause autoimmunity, which is mitigated by inhibiting the mechanistic target of rapamycin. However, once tolerance is established, self-specific CD8 T cells display a gene signature comparable to tumor-specific CD8 T cells in a fixed state of dysfunction. Tolerant self-specific CD8 T cells do not respond to single or combinatorial dosing of anti-CTLA4, anti–PD-L1, anti–PD-1, anti–LAG-3, and/or anti–TIM-3. Despite this, T cell responsiveness can be induced by vaccination with cognate antigen, which alters the previously fixed transcriptional signature and increases antigen-sensing machinery. Antigenic reeducation of tolerant T cells synergizes with checkpoint blockade to generate functional CD8 T cells, which eliminate tumors without concomitant autoimmunity and are transcriptionally distinct from classic effector T cells. These data demonstrate that responses to checkpoint blockade are dependent on the activation state of a T cell and show that checkpoint blockade-insensitive CD8 T cells can be induced to respond to checkpoint blockade with robust antigenic stimulation to participate in tumor control.

AB - Established T cell dysfunction is a barrier to antitumor responses, and checkpoint blockade presumably reverses this. Many patients fail to respond to treatment and/or develop autoimmune adverse events. The underlying reason for T cell responsiveness remains elusive. Here, we show that susceptibility to checkpoint blockade is dependent on the activation status of T cells. Newly activated self-specific CD8 T cells respond to checkpoint blockade and cause autoimmunity, which is mitigated by inhibiting the mechanistic target of rapamycin. However, once tolerance is established, self-specific CD8 T cells display a gene signature comparable to tumor-specific CD8 T cells in a fixed state of dysfunction. Tolerant self-specific CD8 T cells do not respond to single or combinatorial dosing of anti-CTLA4, anti–PD-L1, anti–PD-1, anti–LAG-3, and/or anti–TIM-3. Despite this, T cell responsiveness can be induced by vaccination with cognate antigen, which alters the previously fixed transcriptional signature and increases antigen-sensing machinery. Antigenic reeducation of tolerant T cells synergizes with checkpoint blockade to generate functional CD8 T cells, which eliminate tumors without concomitant autoimmunity and are transcriptionally distinct from classic effector T cells. These data demonstrate that responses to checkpoint blockade are dependent on the activation state of a T cell and show that checkpoint blockade-insensitive CD8 T cells can be induced to respond to checkpoint blockade with robust antigenic stimulation to participate in tumor control.

KW - CD8 T cells

KW - Checkpoint

KW - Dysfunction

KW - Tolerance

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=85061369553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061369553&partnerID=8YFLogxK

U2 - 10.1073/pnas.1810326116

DO - 10.1073/pnas.1810326116

M3 - Article

C2 - 30679280

AN - SCOPUS:85061369553

VL - 116

SP - 2640

EP - 2645

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 7

ER -